2024 ESC热点聚焦：12场热线会议，38项Hot Line研究引领学术前沿

时间：8月30日，11:00-12:09

会场：London

•HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy

3期HELIOS-B研究主要结果：Vutrisiran治疗转甲状腺素蛋白淀粉样变心肌病（ATTR-CM）患者

•Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control

ABYSS试验结果及其对血压和心率控制的影响：既往心肌梗死患者停用β受体阻滞剂

•STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial

STOP-or-NOT研究：一项多中心随机对照试验，评估肾素-血管紧张素系统抑制剂持续使用与停用对术后并发症的影响

时间：8月31日，08:15-09:46

会场：London

•The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity

BedMed和BedMed-Frail随机对照试验：降压时机对死亡率和并发症的影响

•Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail

降压药物睡前服药试验的荟萃分析，包括来自BedMed和BedMed Frail试验的个体患者数据

•GMRx2 - Efficacy and safety of a novel triple single pill combination

新型三药单片复方制剂GMRx2（含替米沙坦、氨氯地平和吲哒帕胺）治疗高血压的有效性和安全性

•QUADRO - A single 4-drug combination in hypertension

QUADRO——单片四药联合治疗高血压

•VERONICA-Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA

VERONICA-Nigeria研究：在非洲提供最佳血压控制

时间：8月31日，11:00-12:06

会场：London

•RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

RESHAPE-HF2研究：经皮修复症状性心力衰竭患者中重度或重度功能性二尖瓣反流

•MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

MATTERHORN研究：在心力衰竭合并继发性二尖瓣反流患者中，经导管二尖瓣修复术和外科二尖瓣修复术的比较

•Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

TRI.FR多中心随机试验：经导管缘对缘修复术治疗严重孤立性继发性三尖瓣反流

时间：8月31日，16:15-17:21

会场：London

•ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery

ASSURE DES研究：非心脏手术前冠状动脉支架置入患者的围手术期抗血小板治疗

•SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting

SWEDEGRAFT研究：“不接触”静脉移植物取材技术在冠状动脉旁路移植术（CABG）中的应用

•The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery

TIGHT-K试验：心脏手术后补钾与房颤预防

时间：8月31日，17:35-18:41

会场：London

•NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

NOTION-3研究：经导管主动脉瓣置入术（TAVI）患者的经皮冠状动脉介入治疗（PCI）

•POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

POPULAL PAUSE TAVI研究：TAVI期间继续or中断口服抗凝治疗？

•RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

RHEIA研究：女性重度主动脉瓣狭窄患者经导管主动脉瓣置换术和外科主动脉瓣置换术的比较

时间：9月1日，08:15-09:41

会场：London

•STEEER-AF - Stroke prevention and rhythm control therapy

STEEER-AF研究：卒中预防和节律控制治疗

•OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation

OCEANIC-AF研究：Asundexian和阿哌沙班抗凝治疗在房颤患者中的比较

•EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease

EPIC-CAD研究：艾多沙班单药与双联抗血栓治疗房颤合并稳定型冠状动脉疾病的比较